Singular Genomics Systems, Inc. announced a partnership with Watchmaker Genomics to validate its Watchmaker DNA Library Prep Kits with Fragmentation for the G4 sequencing platform. Precision tools are needed across the entire genomics workflow from sample input to information output with library preparation being a critical determinant of data quality. Watchmaker solutions are designed to enable the development of highly sensitive, streamlined assays to unlock valuable insights from a variety of sample types.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.68 USD | +3.58% |
|
+13.91% | -37.12% |
07-15 | Singular Genomics Regains Nasdaq Compliance | MT |
07-09 | Goldman Sachs Adjusts Price Target on Singular Genomics Systems to $6.50 From $22.50, Maintains Neutral Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.12% | 21.44M | |
+23.40% | 47.96B | |
+0.12% | 42.45B | |
+43.96% | 41.47B | |
+25.92% | 31.6B | |
+19.50% | 28.63B | |
-4.47% | 28.03B | |
+51.21% | 14.56B | |
+43.85% | 14.14B | |
+2.02% | 12.58B |
- Stock Market
- Equities
- OMIC Stock
- News Singular Genomics Systems, Inc.
- Singular Genomics Partners with Watchmaker Genomics to Enable the Watchmaker DNA Library Prep Kits for the G4 Sequencing Platform